- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Cancer Of Prostate in Poland
Total 4283 results
-
VA Office of Research and DevelopmentRecruitingMetastatic Castrate Resistant Prostate Cancer | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | RAD51B, RAD51C, RAD51D, or RAD54L MutationsUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
Dana-Farber Cancer InstituteAmbry GeneticsCompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Metastatic Prostate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Achieve Life SciencesCompletedProstate CancerFrance, United States, Canada, Australia, Hungary, Czech Republic, Russian Federation, United Kingdom
-
Jagiellonian UniversityTerminatedPain | Pain, Postoperative | Prostatic Cancer | Anesthetics, LocalPoland
-
Centre of Postgraduate Medical EducationCompletedProstate CancerPoland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate Cancer | Metastatic CancerUnited States
-
Bristol-Myers SquibbCompletedNeoplasm Metastasis | Prostate CancerUnited States
-
Cell GenesysTerminatedProstate CancerUnited States, France, Belgium, Canada, United Kingdom, Sweden, Netherlands, Germany
-
Janssen Research & Development, LLCCompletedProstate CancerUnited States, Australia, France, United Kingdom, Belgium, Germany, Spain, Canada, Netherlands, Greece, Sweden
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
CelgeneCompletedProstate CancerUnited States, Spain, France, Belgium, Australia, Denmark, Austria, United Kingdom, Netherlands, Poland, Israel, Italy, Germany, Greece, Canada, Czechia, Hungary, Mexico, Russian Federation, South Africa, Sweden
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
BayerOrion Corporation, Orion PharmaCompletedMetastatic Hormone-sensitive Prostate CancerBelgium, France, Sweden, China, Canada, United States, Spain, Taiwan, Japan, Finland, Korea, Republic of, Australia, Brazil, Czechia, Israel, Italy, Netherlands, Russian Federation, Bulgaria, United Kingdom, Germany, Poland, Mexico
-
Active Biotech ABCompletedProstate CancerFrance, Poland, Ukraine, United Kingdom, United States, China, Germany, Taiwan, Spain, Belgium, Colombia, Israel, Bulgaria, India, Panama, Romania, Netherlands, Greece, Sweden, Korea, Republic of, Australia, Canada, Chile, New Zealand, ... and more
-
Ferring PharmaceuticalsMemorial Sloan Kettering Cancer Center; Duke Clinical Research InstituteTerminatedProstate CancerUnited States, France, Canada, Czechia, Finland, Germany, Greece, Poland, Russian Federation, Slovakia, South Africa, United Kingdom
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, France, United States, Australia, Brazil, Germany, Taiwan, Denmark, China, Netherlands, Japan, Canada, Finland, Italy, Hungary, Portugal, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
VA Office of Research and DevelopmentActive, not recruitingProstate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical... and other collaboratorsActive, not recruitingProstate CancerUnited States, Canada
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
zr Pharma & GmbHFoundation MedicineCompletedMetastatic Castration Resistant Prostate CancerUnited States, Spain, United Kingdom, France, Australia, Belgium, Denmark, Israel, Germany, Ireland, Canada, Italy
-
AstraZenecaTerminatedProstate CancerSweden, United States, Brazil, Czech Republic, France, Italy, Peru, Russian Federation, Spain, Turkey, United Kingdom, Germany, China, Hungary, Latvia, Poland, Romania, Japan, Finland, Norway, Canada, South Africa, Argentina, Australia, Belgiu... and more
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma in the Soft Tissue | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the BoneUnited States, Puerto Rico
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Canada
-
Aragon Pharmaceuticals, Inc.Active, not recruiting
-
Wielkopolskie Centrum Pulmonologii i TorakochirurgiiMedtronicCompletedLung Cancer | Complication of Surgical ProcedurePoland
-
Brown UniversityTerminatedMelanoma | Prostate Cancer | Renal CancerUnited States
-
National Cancer Institute (NCI)Recruiting
-
AstraZenecaRecruitingProstate CancerUnited States, Spain, United Kingdom, Netherlands, Canada, Australia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology Group and other collaboratorsCompletedProstate CancerUnited States, Australia, Peru, Puerto Rico
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada, Puerto Rico
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science UniversityCompleted
-
University of FloridaPatient-Centered Outcomes Research InstituteActive, not recruitingProstate CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Southwest Oncology GroupCompletedProstate CancerUnited States, Canada
-
Myrexis Inc.UnknownProstate CancerUnited States